5P - HER2DX risk-score in HER2-positive (HER2+) breast cancer following neoadjuvant and adjuvant anti-HER2-based treatment: an updated survival analysis (ID 225)
Presentation Number
5P
Speakers
Olga Martinez Saez (Barcelona, Spain)
Authors
Olga Martinez Saez (Barcelona, Spain)
Fara Brasó-Maristany (Barcelona, Spain)
Gaia Griguolo (Padova, Italy)
Laia Pare Brunet (Barcelona, Spain)
Maria Vittoria Dieci (Padova, Italy)
Javier Cortes (Madrid and Barcelona, Spain)
Antonio Llombart Cussac (Valencia, Spain)
Guillermo Villacampa (Barcelona, Spain)
Mercedes Marín-Aguilera (Barcelona, Spain)
Maria Rey (Barcelona, Spain)
Gerard Goberna (Barcelona, Spain)
Montserrat Munoz (Barcelona, Spain)
Ana Vivancos (Barcelona, Spain)
Patricia Villagrasa Gonzalez (Barcelona, Spain)
Joel Parker (Chapel Hill, United States of America)
Pier Franco Conte (Padova, Italy)
Aleix Prat (Barcelona, Spain)
Tomas Pascual (Barcelona, Spain)
Valentina Guarneri (Padova, Italy)
Presentation Topic
Biomarkers and translational research and precision medicine